Abcuro, Inc. BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

NCT07746141 clinical trial report covering Tislelizumab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07744646 clinical trial report covering Alpha-0261, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07744152 clinical trial report covering BI 3822971 (Boehringer Ingelheim GmbH), Phase 1, endpoints, sponsor, geography, readout timing and development w

NCT07726576 clinical trial report covering Venetoclax, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07725705 clinical trial report covering Zeprumetostat, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07730515 clinical trial report covering Igermetostat, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07734116 clinical trial report covering ONO-4538HSC, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07733349 clinical trial report covering UX-DA003, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07734649 clinical trial report covering RSV/hMPV mRNA Vaccine (Sanofi), Phase 1/2, endpoints, sponsor, geography, readout timing and development white s

NCT07735104 clinical trial report covering QLS2319, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07734077 clinical trial report covering Momelotinib Dihydrochloride, Phase 1/2, endpoints, sponsor, geography, readout timing and development white spac